Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
PureTech Health (GB:PRTC)
:PRTC
PRTC Stock Chart & Stats
Day’s Range― - ―
52-Week Range132.80p - 238.50p
Previous CloseN/A
Volume88.39K
Average Volume (3M)320.63K
Market Cap
£350.51M
Enterprise Value314.79M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta1.55
Next Earnings
Apr 24, 2025EPS Estimate
-22.36Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.24
Shares Outstanding239,421,310
10 Day Avg. Volume234,475
30 Day Avg. Volume320,631
Standard Deviation0.11
R-Squared0.15
Alpha-0.01
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)580.33
Price to Cash Flow (P/CF)-2.70
P/FCF Ratio0.00
Enterprise Value/Market Cap0.90
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-3.30
Enterprise Value/Ebitda-1.55
Forecast
1Y Price Target
455.00pPrice Target Upside211.64% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
PureTech Health News
PremiumCompany Announcements
PureTech’s Vedanta Biosciences Advances with Promising VE303 Study Results
PremiumCompany Announcements
PureTech’s LYT-200 Receives FDA Fast Track Designation for AML
PremiumCompany Announcements
PureTech Health to Present at J.P. Morgan Healthcare ConferencePremiumCompany Announcements
PureTech Health Appoints UBS as UK Corporate Broker
---
Options Prices
Currently, No data available
---
Ownership Overview
8.73% Insiders
11.60% Mutual Funds
0.11% Other Institutional Investors
77.60% Public Companies and
Individual Investors
PRTC FAQ
What was PureTech Health’s price range in the past 12 months?
PureTech Health lowest share price was 132.80p and its highest was 238.50p in the past 12 months.
What is PureTech Health’s market cap?
PureTech Health’s market cap is £350.51M.
When is PureTech Health’s upcoming earnings report date?
PureTech Health’s upcoming earnings report date is Apr 24, 2025 which is in 62 days.
How were PureTech Health’s earnings last quarter?
PureTech Health released its earnings results on Aug 28, 2024. The company reported -0.119p earnings per share for the quarter, beating the consensus estimate of -0.24p by 0.121p.
Is PureTech Health overvalued?
According to Wall Street analysts PureTech Health’s price is currently Undervalued.
Does PureTech Health pay dividends?
PureTech Health does not currently pay dividends.
What is PureTech Health’s EPS estimate?
PureTech Health’s EPS estimate is -22.36.
How many shares outstanding does PureTech Health have?
PureTech Health has 239,421,310 shares outstanding.
What happened to PureTech Health’s price movement after its last earnings report?
PureTech Health reported an EPS of -0.119p in its last earnings report, beating expectations of -0.24p. Following the earnings report the stock price went up 2.788%.
Which hedge fund is a major shareholder of PureTech Health?
Currently, no hedge funds are holding shares in GB:PRTC
---
PureTech Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
455.00p (211.64% Upside)
455.00p (211.64% Upside)
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-24.43%
12-Months-Change
Fundamentals
Return on Equity
-20.03%
Trailing 12-Months
Asset Growth
-15.90%
Trailing 12-Months
Company Description
PureTech Health
PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on areas of growing scientific and technical insights that it believes are at an important inflection point, including the central nervous, gastrointestinal and immune systems, and the interactions and signaling between them. The company has a robust pipeline of advanced programs that are post-human proof of concept, focused on addressing some of the society's healthcare needs.
---
PRTC Stock 12 Month Forecast
Average Price Target
455.00p
▲(211.64% Upside)
Technical Analysis
Avacta Group plc
―
Futura Medical
―
HUTCHMED (China) Limited
―
Scancell Holdings
―
Oxford BioMedica
―
Best Analysts Covering PRTC
1 Year
1 Year Success Rate
3/12 ratings generated profit
1 Year Average Return
-7.64%
reiterated a buy rating 2 months ago
Copying Peter Welford's trades and holding each position for 1 Year would result in 25.00% of your transactions generating a profit, with an average return of -7.64% per trade.
---